Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate

Crystalline and amorphous forms of 17-alpha-hydroxyprogesterone caproate

US Patent 10556922 · Granted Feb 11, 2020

Estimated economic value: $4,609,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohex2024
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,62022
Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quin2022
Process of making somatostatin modulators2021
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,62020
Process of making somatostatin modulators2019
Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,62019
Maleate salts of (E)-N-{4[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-etho2018
Process of preparing low ABUK oxymorphone hydrochloride2018
Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic a2017
Solid salt form of α-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof2017
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-eth2017